Amneal Pharmaceuticals (AMRX) FCF Margin (2017 - 2026)

Amneal Pharmaceuticals' FCF Margin history runs 10 years deep, the most recent figure standing at 4.83% for Q1 2026.

• In Q1 2026, FCF Margin fell 401.0% year-over-year to 4.83%; the TTM figure through Mar 2026 stood at 7.9% (down 97.0% YoY), while the FY2025 annual figure was 8.94%, up 24.0% from the prior year.
• FCF Margin was 4.83% for Q1 2026 at Amneal Pharmaceuticals, down from 13.33% in the prior quarter.
• In the past five years, FCF Margin ranged from a high of 3777.59% in Q1 2022 to a low of 23.34% in Q2 2022.
• Historically, FCF Margin has averaged 228.51% across 5 years, with a median of 11.25% in 2023.
• The sharpest annual moves came in 2022 and 2023: FCF Margin jumped 374993 bps in 2022, then plunged 375427 bps in 2023.
• A 5-year view of FCF Margin shows it stood at 2.2% in 2022, then soared by 830 bps to 20.42% in 2023, then slumped by 31 bps to 14.09% in 2024, then decreased by 5 bps to 13.33% in 2025, then plunged by 136 bps to 4.83% in 2026.
• The last three FCF Margin figures came in at 4.83% (Q1 2026), 13.33% (Q4 2025), and 13.53% (Q3 2025), per Business Quant data.